Related by context. All words. (Click for frequent words.) 74 thromboembolic events 74 recurrent DVT 73 symptomatic VTE 73 Erythropoietic therapies may 73 β blockers 73 non valvular atrial 72 thrombotic complications 72 thromboembolism 71 unstable angina pectoris 71 thrombotic events 71 postoperative AF 71 EXJADE 71 hemorrhagic complications 71 morphometric vertebral fractures 70 macrovascular events 70 colorectal adenoma 70 recurrent VTE 70 neutropenia dehydration dyspnea 70 Stent thrombosis 70 perioperatively 70 thromboembolic 70 invasive candidiasis 70 periprocedural 70 cerebrovascular events 70 hypercalciuria 70 arterial thromboembolic events 70 Torsades de Pointes 70 heparin induced thrombocytopenia 70 Postoperative complications 70 neurologic complications 69 ischemic cardiomyopathy 69 reinfarction 69 hepatotoxicity 69 NATRECOR ® 69 prolonged QT interval 69 recurrent venous thromboembolism 69 venous thromboembolic disease 69 torsade de pointes 69 antiarrhythmic drug 69 myocardial infarction stroke 69 nonfatal MI 69 carotid artery blockage 69 angiographically 69 thromboprophylaxis 69 TNF antagonist 69 coronary stenosis 69 Hypotension 69 pyelonephritis 69 postoperative complication 69 Toxicities 69 aspirin clopidogrel 69 PLX STROKE targeting 68 induce orthostatic hypotension 68 coronary stenoses 68 myopathy rhabdomyolysis 68 nonischemic 68 transaminase elevations 68 artery stenosis 68 TMP SMX 68 renal toxicity 68 intravesical therapy 68 urolithiasis 68 invasive aspergillosis 68 transfusion syndrome 68 nonvertebral fractures 68 postoperative pulmonary 68 flutamide 68 drug eluting stent implantation 68 ATACAND 68 thromboses 68 hemodynamically significant 68 Febrile neutropenia 68 definite stent thrombosis 68 QT prolongation 68 leiomyomas 68 cerebral vasospasm 68 silent ischemia 68 serum phosphorous 68 left ventricular dysfunction 68 symptomatic pulmonary embolism 68 relapsed MM 68 FRAGMIN 68 mycophenolate mofetil 68 rFVIIa 68 androgen deprivation 68 leucopenia 68 hypercalcemia 68 peripheral arterial occlusive disease 68 upper gastrointestinal bleeding 68 postoperative atrial fibrillation 68 fluvastatin 68 nonvertebral fracture 68 antithrombotic therapy 68 venous thromboembolic events 68 cytopenias 68 endometrial hyperplasia 68 hypomagnesemia 68 pyrexia mucositis sepsis febrile 68 patients undergoing percutaneous 68 antiplatelet medications 67 MULTAQ 67 stable angina 67 nonfatal stroke 67 PEGINTRON TM 67 HeFH 67 included exfoliative dermatitis 67 ertapenem 67 perioperative mortality 67 intracranial atherosclerosis 67 advanced adenoma 67 endophthalmitis 67 elevated IOP 67 rebleeding 67 acetabular dysplasia 67 non splenectomized 67 hyperalgesia 67 thyrotoxicosis 67 pericardial effusion 67 certolizumab 67 primidone 67 lichen planus 67 postoperative infections 67 carotid stenosis 67 dyslipidaemia 67 atherothrombotic events 67 ß blockers 67 VTE prophylaxis 67 thromboembolic disease 67 proximal DVT 67 FluCAM arm 67 CrCl 67 tricuspid regurgitation 67 gastrointestinal perforation 67 severe neutropenia 67 postoperative delirium 67 HIV HCV coinfected 67 subtrochanteric 67 Eisenmenger syndrome 67 COPD exacerbation 67 atherosclerotic vascular disease 67 noncardiovascular 67 platelet inhibitor 67 renal scarring 67 chorioamnionitis 67 nicardipine 67 nephrotoxicity 67 nonfatal pulmonary embolism 67 Endothelial dysfunction 67 intravenous bisphosphonates 67 graft occlusion 67 aminotransferases 67 atherogenic dyslipidemia 67 noncardiac 67 AA Amyloidosis 67 ICD shocks 67 colorectal liver metastases 67 severe hypersensitivity reactions 67 intraoperative complications 67 QT interval prolongation 67 INVEGA ® 67 recurrent atrial fibrillation 67 GP IIb IIIa inhibitors 67 Serious adverse reactions 67 bypass grafting 67 mitral stenosis 67 moderate renal impairment 67 perioperative morbidity 67 gastric adenocarcinoma 67 ischemic complications 67 symptomatic intracranial 67 CTAP# Capsules 67 T1c 67 systolic dysfunction 67 extrapyramidal symptoms 67 recurrent ischemia 67 candidemia 67 recurrent myocardial infarction 67 coagulopathy 67 beta blocker therapy 66 paroxysmal AF 66 acute GVHD 66 systemic hypotension 66 lipid lowering agents 66 MACCE 66 nondiabetic patients 66 tumor lysis syndrome 66 grade cervical intraepithelial 66 mild renal impairment 66 symptomatic hyponatremia 66 hyperacute 66 perioperative complications 66 NYHA Class II 66 HMG CoA reductase inhibitors 66 SGPT 66 intracerebral 66 revascularization procedures 66 bacterial prostatitis 66 intima media thickness 66 hypocalcemia 66 patients undergoing CABG 66 Renal dysfunction 66 interferon alfa 2b 66 antiplatelet drugs 66 hyperkalemia 66 allogeneic HSCT 66 locoregional recurrence 66 Doxil ® 66 prostate cancer CaP 66 alpha interferons 66 hyperphenylalaninemia HPA due 66 hepatorenal syndrome 66 ximelagatran 66 Avandia Actos 66 unfractionated heparin UFH 66 revascularizations 66 renal dysfunction 66 coinfected patients 66 atrial arrhythmias 66 Pulmonary embolism 66 intrathoracic 66 secondary hyperparathyroidism 66 ischemia driven 66 deep venous thromboses 66 Navelbine ® 66 CMV disease 66 paroxetine Paxil 66 torsades de pointes 66 nasopharyngitis headache 66 mcg BID 66 elevated triglyceride levels 66 intracranial hemorrhage ICH 66 myocardial infarction ventricular fibrillation 66 elevated ALT 66 stenoses 66 elevated serum creatinine 66 Atherosclerotic 66 Primary endpoints 66 vesicoureteral reflux 66 primary aldosteronism 66 CVD mortality 66 salmeterol fluticasone 66 Tasigna prolongs 66 gastrointestinal toxicity 66 T2DM 66 antiphospholipid antibodies 66 NSAID associated 66 CIMZIA ™ 66 adrenal suppression 66 receiving XGEVA 66 dermatologic reactions 66 hypervascular tumors 66 TEAEs 66 abacavir lamivudine 66 Infusion Reactions Severe 66 bronchopulmonary dysplasia BPD 66 LV dysfunction 66 serum aminotransferase levels 66 gadobutrol 66 valvular disease 66 subclinical hypothyroidism 66 mild renal insufficiency 66 hypercholesterolaemia 66 pretest probability 66 hypophosphatemia 66 macrovascular 66 adrenal insufficiency 66 postoperative morbidity 66 antiphospholipid syndrome 66 thrombo embolic 66 cytomegalovirus infection 66 INFERGEN 66 pioglitazone HCl 66 pentoxifylline 66 HBeAg negative 66 ABCB1 66 atherothrombotic disease 66 beclomethasone dipropionate 66 arterial thrombotic 66 unresectable tumors 66 eplerenone 66 IIIa inhibitor 66 K ras mutations 66 hemostatic efficacy 66 hsCRP levels 66 hypocalcaemia 66 AST ALT 66 osteopenic 66 CP CPPS 66 parecoxib 66 deferiprone 66 adrenalectomy 66 aspartate aminotransferase 66 anemia thrombocytopenia 66 somatostatin analog 66 mycophenolic acid 66 Thiazolidinediones 66 angiographic outcomes 66 labetalol 66 sotalol 66 ventricular tachyarrhythmia 66 histologic subtype 66 acute humoral rejection 66 atherothrombotic 66 grade squamous intraepithelial 66 variceal hemorrhage 66 paricalcitol 66 haematologic 66 pulmonary infiltrates 66 anemia neutropenia 66 somatostatin analogues 66 decompensated cirrhosis 66 Ribavirin causes 66 ADPKD 66 aldosterone antagonist 66 ipsilateral stroke 66 contrast induced nephropathy 66 Warfarin Coumadin 66 aminotransferase levels 66 liver transplant recipients 66 severe renal impairment 66 hematologic toxicity 66 venous thromboembolism 66 dopaminergic therapy 66 metastatic malignant 66 cholestasis 66 hypoperfusion 65 decompensated liver disease 65 pulmonary dysfunction 65 adjunctive placebo 65 venlafaxine Effexor 65 acute aortic dissection 65 renal artery stenosis 65 Renal impairment 65 orchitis 65 infective endocarditis 65 lipid elevations 65 hyperprolactinemia 65 Atypical Hemolytic Uremic Syndrome 65 BENICAR HCT 65 pharmacokinetic interactions 65 Ischemic 65 myocardial infarctions 65 anterior uveitis 65 occlusive disease 65 invasive fungal infection 65 LVSD 65 syncope fainting 65 systemic corticosteroid 65 oral anticoagulation 65 glycated hemoglobin levels 65 purpura ITP 65 R Saizen R 65 ARIXTRA 65 neoplasias 65 PHPT 65 macroalbuminuria 65 pheochromocytoma 65 corticosteroid therapy 65 cisplatin gemcitabine 65 Thrombocytopenia 65 INCB# [003] 65 symptomatic aortic stenosis 65 intracerebral haemorrhage 65 unresectable HCC 65 Index CDAI 65 β blocker 65 recurrent glioblastoma multiforme 65 antiarrhythmic drugs 65 PAOD 65 saline placebo 65 overt nephropathy 65 NMIBC 65 serum calcium levels 65 interstitial pneumonitis 65 PEGylated interferon beta 1a 65 Venous thromboembolism 65 GH deficiency 65 cardiac dysfunction 65 PRADAXA 65 XIENCE V PROMUS Stent 65 endometrial carcinoma 65 platelet reactivity 65 cholecystitis 65 Chronic pancreatitis 65 MAGE A3 ASCI 65 receiving VELCADE 65 biologic DMARD 65 ARCOXIA 65 carotid endarterectomy CEA 65 serum phosphate 65 IOP lowering 65 non metastatic osteosarcoma 65 nephrolithiasis 65 polyp recurrence 65 G6PD deficiency 65 pulmonary exacerbations 65 pericardial effusions 65 trimethoprim sulfamethoxazole 65 reactogenicity 65 pulmonary artery hypertension 65 VIIBRYD 65 Nesiritide 65 microvascular disease 65 riociguat 65 mcg QD 65 nonoperative treatment 65 cholangiocarcinoma 65 nonhematologic adverse reactions 65 post thrombotic syndrome 65 Aggrastat ® tirofiban hydrochloride 65 FASLODEX 65 neutropaenia 65 myelodysplastic myeloproliferative diseases 65 everolimus eluting stents 65 calcaneal fractures 65 PRADAXA #mg 65 Subgroup analyzes 65 antiepileptic medications 65 pulmonary artery banding 65 diabetic kidney 65 ventricular fibrillation VF 65 percutaneous vertebroplasty 65 either acutely decompensated 65 mediastinitis 65 milrinone 65 dual endothelin receptor antagonist 65 hemodilution 65 varicella infection 65 variant angina 65 hematological parameters 65 liver histology 65 cervical lymph nodes 65 cerebral infarction 65 radiotherapy RT 65 immunosuppressive regimen 65 dose atorvastatin 65 reoperations 65 thienopyridines 65 thrombocytopenic 65 recurrent miscarriage 65 mitral insufficiency 65 mycophenolate mofetil MMF 65 NNT = 65 dalteparin 65 Deep venous thrombosis 65 neutropenic fever 65 carotid artery stenosis 65 ACTOS ® 65 nonfatal myocardial infarction 65 HER2 expression 65 enalapril 65 cervicitis 65 CHD CVD 65 spinal metastases 65 arterial calcification 65 anticlotting drugs 65 microvascular complications 65 erythema nodosum 65 carotid IMT 65 weekly subcutaneous injections 65 aortic regurgitation 65 Angioedema 65 infarctions 65 intracranial stenosis 65 malperfusion 65 severe mitral regurgitation 65 Statin therapy 65 Subarachnoid hemorrhage 65 Known hypersensitivity 65 neurological complications 65 aldosterone antagonists 65 proliferative diabetic retinopathy 65 acute GvHD 65 postoperative chemotherapy 65 rheumatoid arthritis osteoarthritis ankylosing 65 hepatic metastases 65 androgen ablation 65 posaconazole 65 thrombus aspiration 65 mixed hyperlipidemia 64 Atypical antipsychotics 64 failure ADHF 64 clinicopathological features 64 dose Iluvien 64 coadministration 64 lactic acidosis 64 thrombophlebitis 64 Fluid retention 64 R# #mg BID 64 moderate hepatic impairment 64 surgical revascularization 64 Proteinuria 64 vasogenic edema 64 Pemetrexed 64 malignant neoplasm 64 COPEGUS therapy 64 angioneurotic edema 64 obstructive coronary artery 64 QTc prolongation 64 receiving prophylactic anticoagulation 64 thrombocytosis 64 pamidronate 64 angina myocardial infarction 64 CIN2 + 64 platelet dysfunction 64 serum urate levels 64 prednisone prednisolone plus 64 intravitreal injections 64 abnormal uterine bleeding 64 STRIDE PD 64 hematopoietic cancers 64 nadolol 64 retinal vein occlusion 64 thrombocytopenia neutropenia 64 malabsorptive 64 clopidogrel Plavix 64 antibiotic prophylaxis 64 recurrent UTI 64 glomerular filtration 64 neurologic deficits 64 fibrinolysis 64 oral Hycamtin 64 ventricular dysfunction 64 undergoing peritoneal dialysis 64 predisposing factor 64 cardiovascular hospitalization 64 TNF Tumor Necrosis Factor 64 detrusor overactivity 64 atrial tachyarrhythmias 64 J Am Coll 64 decompensated heart failure 64 pulmonary embolism PE 64 bezafibrate 64 gestational hypertension 64 chronic periodontitis 64 delayed CINV 64 PASI scores 64 sinus node dysfunction 64 Adjuvant chemotherapy 64 spontaneous bacterial peritonitis 64 Non inferiority 64 obstructive coronary 64 CIMZIA R 64 preserved ejection fraction 64 thrombophilia 64 multivessel disease 64 pT3 64 ribavirin therapy 64 neurologic symptoms 64 ® lenalidomide 64 alteplase 64 Tardive dyskinesia 64 dysrhythmias 64 NSTEMI 64 PCNSL 64 hepatic failure 64 adriamycin 64 femoral neck fracture 64 binary restenosis 64 Non Alcoholic Steatohepatitis 64 gallstone disease 64 postoperative mortality 64 severe exacerbations 64 retinal vein occlusion induced 64 acute coronary syndromes ACS 64 plasma pharmacokinetics 64 clinically meaningful reductions 64 cryptogenic stroke 64 lumiracoxib 64 bronchial hyperresponsiveness 64 Microalbuminuria 64 benazepril 64 epoetin beta 64 ACTEMRA TM 64 gastric carcinoma 64 gastric cardia 64 parathyroid carcinoma 64 ventricular arrhythmia 64 hypertension diabetes mellitus 64 headache abdominal pain 64 Cardiopulmonary bypass 64 intra articular injection 64 neonatal morbidity 64 leukoencephalopathy 64 unfavorable cytogenetics 64 vertebral fracture 64 DU #b 64 beta blockers ACE inhibitors 64 paclitaxel eluting stents 64 risperidone Risperdal 64 NAVISTAR R 64 venous thromboembolisms 64 CYT# potent vascular disrupting 64 coinfection 64 Primary Hypercholesterolemia 64 overt hepatic encephalopathy HE 64 clevidipine 64 alanine aminotransferase 64 System IPSS 64 cinacalcet 64 echocardiographic parameters 64 hepatic enzymes 64 malignant neoplasms 64 plasma kallikrein inhibitor 64 Vidaza ® 64 cerebrovascular accidents 64 elevated transaminases 64 mL/min/#.# m 2 64 postoperative infection 64 Radical prostatectomy 64 Candida infection 64 NATRECOR R 64 nonalcoholic steatohepatitis NASH 64 resynchronization therapy 64 bisoprolol 64 invasive ductal 64 dysglycemia 64 alfuzosin 64 macular holes 64 Legg Calvé Perthes disease 64 CYPHER R Sirolimus eluting 64 sitaxsentan 64 antiandrogens 64 CTEPH 64 systemic embolism 64 renal insufficiency 64 FUSILEV enhances 64 hemorrhagic cystitis 64 haloperidol Haldol 64 sonographic appearance 64 administered concomitantly 64 Severe Primary IGFD 64 grade cervical dysplasia 64 varices 64 cTnI 64 Certolizumab pegol 64 histological subtype 64 atrophic gastritis 64 primary hyperparathyroidism 64 symptomatic paroxysmal AF 64 nonalcoholic steatohepatitis 64 angiotensin converting enzyme inhibitors 64 clazosentan 64 vasospasm 64 COPD exacerbations 64 IV bisphosphonates 64 LV ejection fraction 64 macrovascular disease 64 atherosclerotic renal artery stenosis 64 rhythm disturbances 64 Natalizumab 64 INTEGRILIN R 64 bullous pemphigoid 64 Subgroup analysis 64 direct thrombin inhibitors 64 myocardial ischemia 64 NOLVADEX 64 pain palliation 64 Intravitreal injections 64 NIASPAN 64 Teriflunomide 64 paroxetine sertraline 64 candesartan cilexetil 64 nulliparous women 64 capillary leak 64 serum creatinine levels 64 tranylcypromine 64 curative resection 64 cardiac toxicity 64 hyperbilirubinemia 64 composite endpoint 64 efalizumab 64 oral antidiabetic medication 64 intracerebral hemorrhage 64 vWD 64 cardiovascular morbidity 64 severe rotavirus gastroenteritis 64 conventional antipsychotics 64 prostate cancer PCa 64 valvular heart disease 64 poor metabolizers 64 prospectively stratified 64 immunomodulatory therapy 64 fractional shortening 64 dosage regimens 64 arterial thrombosis 64 esophagogastric 64 treat benign prostatic 64 myocardial ischaemia 64 refractory ischemia 64 mild hepatic impairment 64 hyperglycaemia 64 HBeAg seroconversion 64 See WARNINGS 64 BYSTOLIC 64 haemorrhagic strokes 64 liposomal amphotericin B 64 stratifying patients 64 ancrod 64 hyperhomocysteinemia 64 Percutaneous Transluminal Coronary Angioplasty 64 Pegloticase 64 pulmonary emboli 64 angiotensin II receptor blockers 64 R lenalidomide 64 HES CEL 64 neointimal hyperplasia 64 #.#mg/dL 64 invasive fungal infections 64 CIMZIA TM certolizumab pegol 64 anticoagulant warfarin 64 vasculopathy 64 venous blood clots 64 neurological manifestations 64 BoNTA 64 leukotriene receptor antagonists 64 receiving VICTRELIS 64 proliferative retinopathy 64 CYP #A# 64 warfarin sodium 64 bovine thrombin 64 metaplasia 64 salmeterol HFA MDI 64 BEXXAR Therapeutic Regimen 64 GnRH agonists 64 herpes zoster shingles 64 percutaneous transluminal coronary angioplasty 64 electrical cardioversion 64 hepatic toxicity 63 bacteriuria 63 hypertrophic scars 63 baseline serum creatinine 63 anticoagulants blood thinners 63 retrograde ejaculation 63 hypercholesterolemic patients 63 Carvedilol 63 hypoxemia 63 pancreatic insufficiency 63 Sezary syndrome 63 voriconazole 63 Ranolazine 63 inhibit platelet function 63 CMV infection 63 Aprotinin 63 BARACLUDE ® 63 idiopathic thrombocytopenic purpura ITP 63 Events MACE 63 Fibrillex TM 63 5-fluorouracil/leucovorin 63 NPH insulin 63 hepatic cirrhosis 63 Adjunctive 63 completely resected 63 #mg BID [001] 63 epistaxis 63 docetaxel Taxotere ® 63 chronic immune thrombocytopenic 63 intravascular hemolysis 63 cerebral angiography 63 adnexal mass 63 intact parathyroid hormone 63 arterial occlusion 63 transplantation HCT 63 neutropenia thrombocytopenia 63 tolterodine ER 63 Transcatheter aortic valve implantation 63 antiplatelet agent 63 See CLINICAL PHARMACOLOGY 63 nonfasting triglyceride levels 63 NAGS deficiency 63 atrioventricular block 63 inotropes 63 aplastic anemia AA 63 prostate carcinoma 63 vascular endothelial dysfunction 63 antidiabetic drug 63 osteolytic 63 glycoprotein IIb IIIa inhibitors 63 plasma homocysteine 63 cardioembolic stroke 63 renal impairment 63 HIV coinfected 63 virologic failure 63 pelvic lymphadenectomy 63 neutrophil counts 63 HBV infections 63 Lactic acidosis 63 CYPHER Stent 63 GOUT 63 KIF6 carriers 63 corrected QT interval 63 prognostic variables 63 idraparinux 63 lymphocytosis 63 nodal metastases 63 Thromboembolic 63 androgen suppression 63 Patients Receiving 63 genotypic resistance 63 neurocognitive deficits 63 Pulmonary Embolism PE 63 REMINYL ® 63 Anti Bacterial Envelope 63 transferrin saturation 63 tachyarrhythmias 63 Hematologic 63 metastatic neuroendocrine tumors 63 Intravitreal 63 antiangiogenic therapy 63 gastrointestinal GI bleeding 63 immune thrombocytopenic purpura 63 HER2 overexpression 63 urethral stricture 63 smoldering multiple myeloma 63 generalized edema 63 folinic acid 63 Refractory Hodgkin Lymphoma 63 Candesartan 63 acute cholecystitis 63 Hematologic toxicity 63 metformin accumulation 63 piroxicam 63 chronic myocardial ischemia 63 transarterial 63 ACTOplus met XR 63 IGFD 63 hyperparathyroidism 63 histologically confirmed 63 hepatic dysfunction 63 SPRYCEL ® 63 UA NSTEMI 63 antiarrhythmic medications 63 reduce serum phosphate 63 alpha1 antitrypsin deficiency 63 nitrofurantoin 63 invasive carcinomas 63 radiochemotherapy 63 ipsilateral breast 63 liver resection 63 mRCC 63 MDS MPD 63 Ileus 63 urothelial carcinoma 63 Peginterferon Alfa 2a 63 hydrops 63 leiomyoma 63 thrombolytic agents 63 cilostazol 63 DES implantation 63 events MACE 63 osteoporotic vertebral compression fractures 63 erlotinib Tarceva ® 63 osteoporotic vertebral fractures 63 blood dyscrasias 63 benign prostatic hypertrophy BPH 63 basal cell carcinoma BCC 63 thyrotropin 63 tamoxifen Nolvadex ® 63 AGILECT R 63 antimicrobial prophylaxis 63 myocardial infarctions MIs 63 TAXUS Stent 63 Antibiotic prophylaxis 63 nadroparin 63 antiretroviral naïve 63 vitreous floaters 63 Exacerbations 63 angioplasty stenting 63 CLINICAL STUDIES 63 extracapsular extension 63 peripheral sensory neuropathy 63 juvenile idiopathic arthritis JIA 63 GRNCM1 63 Coronary Artery Bypass Graft 63 events TEAEs 63 FRAGMIN R 63 node metastases 63 skeletal metastases 63 cardiomegaly 63 non selective NSAIDs 63 onset atrial fibrillation 63 arteriography 63 polyarticular 63 cytoreductive surgery 63 Non Alcoholic Fatty 63 syncopal 63 TAXUS Express Stent 63 fondaparinux 63 immunomodulatory agents 63 HPA axis suppression 63 deep vein thromboses 63 LOVENOX R 63 optic neuropathy 63 RAPAFLO R 63 nonfatal myocardial infarction MI 63 intraventricular hemorrhage 63 pulmonary resection 63 plasminogen activators 63 acromegalic patients 63 fibrate drugs 63 ALT flares 63 basal bolus regimen 63 NSAID induced 63 micafungin 63 electrolyte abnormalities 63 infusional 63 anastomotic leak 63 hypoglycemic episodes 63 ergot derivatives 63 cerebrovascular accident 63 Mg Uk 63 biochemical relapse 63 hypoglycaemic episodes 63 adjuvant radiotherapy 63 creatinine clearance 63 carcinoid tumor 63 cystic fibrosis chronic pancreatitis 63 aortic valve stenosis 63 SSc 63 hypogonadotropic hypogonadism 63 sinus tachycardia 63 secondary efficacy endpoint 63 HBeAg + 63 Prospective Randomized 63 carotid plaques 63 vascular occlusive diseases 63 extrapyramidal symptoms EPS 63 postmenopausal osteoporotic women 63 stage IIIb IV 63 allograft rejection 63 Octreolin 63 clomipramine 63 APTIVUS r 63 lower extremity amputation 63 liver metastasis 63 cystoid macular edema 63 Peginterferon alfa 2b 63 TAXUS Liberte Long 63 hepatic fibrosis 63 CTAP# 63 ALT elevations 63 Vitamin B# deficiency 63 aspartate aminotransferase AST 63 periprocedural MI 63 rt PA 63 zoledronate 63 inhaled budesonide 63 Relapsing Remitting Multiple Sclerosis 63 autonomic dysfunction 63 hypoglycemic events 63 peginterferon alfa 63 metabolic alkalosis 63 leukopenia 63 grade glioma 63 pyrazinamide 63 receiving immunosuppressive therapy 63 pathologic fractures 63 lipid abnormalities 63 loop diuretic 63 debilitating complication 63 cardiovascular hospitalizations 63 corticosteroid induced 63 C1 INH deficiency 63 AVAPRO 63 Asymptomatic 63 pleural effusions 63 cirrhosis liver failure 63 breast endometrial 63 arthropathy 63 superficial femoral 63 oral rivaroxaban 63 pegylated liposomal doxorubicin 63 acute myocardial infarction MI 63 onset diabetes mellitus 63 SRBD 63 colon perforation 63 primary immunodeficiency PI 63 QT intervals 63 infarction NSTEMI 63 Myelosuppression 63 Lipitor #mg 63 trastuzumab Herceptin ® 63 abacavir Ziagen 63 Severe hypoglycemia 63 thymectomy 63 intensive statin therapy 63 neurodevelopmental impairment 63 adrenocortical cancer 63 ergot alkaloids 63 relapsed Acute Myeloid 63 Thrombolysis 63 oxycodone CR 63 serum IGF 63 T1DM 63 acetonide FA 63 pathologic fracture 63 Carotid Revascularization Endarterectomy vs. 63 Zollinger Ellison Syndrome 63 Uncontrolled hypertension